You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
|
---|---|
Published in |
Journal of Clinical Oncology, December 2018
|
DOI | 10.1200/jco.18.01580 |
Pubmed ID | |
Authors |
Arnon P. Kater, John F. Seymour, Peter Hillmen, Barbara Eichhorst, Anton W. Langerak, Carolyn Owen, Maria Verdugo, Jenny Wu, Elizabeth A. Punnoose, Yanwen Jiang, Jue Wang, Michelle Boyer, Kathryn Humphrey, Mehrdad Mobasher, Thomas J. Kipps |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 33% |
Spain | 2 | 13% |
France | 2 | 13% |
United Kingdom | 1 | 7% |
Saudi Arabia | 1 | 7% |
Unknown | 4 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 73% |
Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Scientists | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 173 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 31 | 18% |
Researcher | 25 | 14% |
Student > Ph. D. Student | 15 | 9% |
Student > Master | 13 | 8% |
Student > Bachelor | 11 | 6% |
Other | 30 | 17% |
Unknown | 48 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 36% |
Biochemistry, Genetics and Molecular Biology | 21 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 8% |
Agricultural and Biological Sciences | 5 | 3% |
Nursing and Health Professions | 3 | 2% |
Other | 15 | 9% |
Unknown | 52 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#937,303
of 25,385,509 outputs
Outputs from Journal of Clinical Oncology
#2,253
of 22,054 outputs
Outputs of similar age
#21,135
of 445,099 outputs
Outputs of similar age from Journal of Clinical Oncology
#43
of 158 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,099 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.